The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Long‐term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only
Abstract
The purpose of this study was to assess long‐term preservation of renal function in 111 patients with systemic lupus erythematosus and active glomerulonephritis who participated in a randomized treatment trial. Four different drug treatment programs, each of which allowed the use of low‐dose oral prednisone in addition to the study drug(s), were compared with a regimen consisting solely of high‐dose oral prednisone. Patients randomized to receive intravenous cyclophosphamide, oral cyclophosphamide, or oral azathioprine plus cyclophosphamide had significantly better preservation of renal function than did patients who were randomized to receive prednisone only. Results in the azathioprine group did not differ from those in the prednisone‐only group. Cyclophosphamide appears to have long‐term benefit in the delay or prevention of end‐stage renal disease in patients with lupus nephritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Spiess, P. E., Lee, A. K., Leibovici, D., Wang, X., Do, K., & Pisters, L. L. (2006) · Cancer · doi:10.1002/cncr.21979 · Cited by 1,930
Austin, H. A., Klippel, J. H., Balow, J. E., Le Riche, N. G. H., Steinberg, A. D., Plotz, P. H., & Decker, J. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603063141004 · Cited by 1,185
Self-citationPrognostic factors in lupus nephritis
Austin, H. A., Muenz, L. R., Joyce, K. M., Antonovych, T. T., Kullick, M. E., Klippel, J. H., Decker, J. L., & Balow, J. E. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90338-8 · Cited by 803
BENEFICIAL EFFECTS OF METHYLPREDNISOLONE "PULSE" THERAPY IN DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS
Cathcart, E., Scheinberg, M., Idelson, B., & Couser, W. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91272-1 · Cited by 246
Felson, D. T., & Anderson, J. (1984) · New England Journal of Medicine · doi:10.1056/nejm198412133112402 · Cited by 233
Comparison of Azathioprine, Prednisone, and Heparin Alone or Combined in Treating Lupus nephritis
Cade, R., Spooner, G. R., Schlein, E. M., Pickering, M. C., de Quesada, A., Holcomb, A., Juncos, L. A., Richard, G. J., Shires, D. L., Levin, D., et al. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180176 · Cited by 144
Hahn, B. H., KANTOR, O. S., & OSTERLAND, C. K. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-5-597 · Cited by 139
Decker, J. L., KLIPPEL, J. H., PLOTZ, P. H., & STEINBERG, A. D. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-5-606 · Cited by 128
Self-citation
Cited by
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
Jones, R. B., Cohen Tervaert, J. W., Hauser, T., Luqmani, R., Morgan, M. D., Peh, C. A., Savage, C. O., Segelmark, M., Tesar, V., van Paassen, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909169 · Cited by 1,748
Hahn, B. H., McMahon, M. A., Wilkinson, A., Wallace, W. D., Daikh, D. I., FitzGerald, J. D., Karpouzas, G. A., Merrill, J. T., Wallace, D. J., Yazdany, J., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21664 · Cited by 1,463
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
Ginzler, E. M., Dooley, M. A., Aranow, C., Kim, M. Y., Buyon, J., Merrill, J. T., Petri, M., Gilkeson, G. S., Wallace, D. J., Weisman, M. H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043731 · Cited by 1,128
Boumpas, D. T., Austin, H. A., Balow, J. E., Vaughan, E. M., Yarboro, C. H., Klippel, J. H., & Steinberg, A. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)92292-n · Cited by 823
Self-citationSequential Therapies for Proliferative Lupus Nephritis
Contreras, G., Pardo, V., Leclercq, B., Lenz, O., Tozman, E., O'Nan, P., & Roth, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031855 · Cited by 818
Boumpas, D. T., Furie, R., Manzi, S., Illei, G. G., Wallace, D. J., Balow, J. E., Vaishnaw, A., & on behalf of the BG9588 Lupus Nephritis Trial Group (2003) · Arthritis & Rheumatism · doi:10.1002/art.10856 · Cited by 618
Gourley, M. F., Austin III, H. A., Scott, D., Yarboro, C. H., Vaughan, E. M., Muir, J., Boumpas, D. T., Klippel, J. H., Balow, J. E., & Steinberg, A. D. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00003 · Cited by 607
Self-citationIllei, G. G., Austin, H. A., Crane, M., Collins, L., Gourley, M. F., Yarboro, C. H., Vaughan, E. M., Kuroiwa, T., Danning, C. L., Steinberg, A. D., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-4-200108210-00009 · Cited by 492
Self-citationMills, J. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302608 · Cited by 407
Immune and Inflammatory Role in Renal Disease
Imig, J. D., & Ryan, M. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120028 · Cited by 356
Prevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290
Guidelines for referral and management of systemic lupus erythematosus in adults
(1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199909)42:9<1785::aid-anr1>3.0.co;2-# · Cited by 269
“Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis
Moroni, G., Quaglini, S., Maccario, M., Banfi, G., & Ponticelli, C. (1996) · Kidney International · doi:10.1038/ki.1996.528 · Cited by 267
Liang, M. H., Schur, P. H., Fortin, P., St.Clair, E. W., Balow, J. E., Costenbader, K., Crofford, L., Pablo, P. D., Dooley, M. A., Finckh, A., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21625 · Cited by 263
ONG, L. M., HOOI, L. S., LIM, T. O., GOH, B. L., AHMAD, G., GHAZALLI, R., TEO, S. M., WONG, H. S., TAN, S. Y., SHAARIAH, W., et al. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00444.x · Cited by 252
Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients
Sidiropoulos, P. I., & Boumpas, D. T. (2004) · Lupus · doi:10.1191/0961203304lu1032oa · Cited by 178
Anti-DNA autoantibodies and systemic lupus erythematosus
Blatt, N. B., & Glick, G. D. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00022-4 · Cited by 60
Metadata
- Authors
- Steinberg, A. D., & Steinberg, S. C.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1991-08
- Volume
- 34
- Issue
- 8
- Pages
- 945-950
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2135212798
- Cited by
- 348
- References
- 11
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.